Newest in Health

U.S. rolls out COVID-19 vaccines for youngest children
Published June 23, 2022
The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week
After Roe falls
Published June 21, 2022
Johns Hopkins experts discuss a future without the safeguards outlined in 'Roe v. Wade'
Women's health
U.S. infertility rate plateaus
Published June 21, 2022
A new analysis of data shows a plateau in infertility rates, but also shows disparities for women of color and for women with less access to health care, highlighting the need for continued work in public health services
Health Policy Forum
Hopkins to host conversation with Donna Shalala
Published June 21, 2022
Shalala, a former HHS secretary and member of Congress, will join Johns Hopkins Health System President Kevin Sowers to discuss health care trends and challenges, leadership, and service
FDA authorizes COVID-19 vaccines for children under 5 years old. What's next?
Published June 16, 2022
Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks
What you need to know about the Novavax vaccine
Published June 16, 2022
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.
Fact vs. Fiction
Debunking myths about gun violence
Published June 13, 2022
Evidence-based solutions to gun violence in America have been shrouded by misinformation and political spin. But experts from Johns Hopkins are setting the record straight.
The pandemic has reached a plateau, but for how long?
Published June 8, 2022
Johns Hopkins health security expert Tom Inglesby provides an update on the state of the pandemic and how vaccination, funding, and variants may affect its future
Antibodies point researchers toward broad coronavirus vaccines
Published June 8, 2022
Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses
Immune response
Risk of breakthrough COVID-19 infection higher among people with HIV
Published June 7, 2022
Finding suggests that all people with HIV might benefit from additional dose in primary vaccination
see more